Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: BLOOD COAGULATION - DRUG EFFECTS , . Treffer: 40

2017

Enko, D; Mangge, H; Münch, A; Niedrist, T; Mahla, E; Metzler, H; Prüller, F Pneumatic tube system transport does not alter platelet function in optical and whole blood aggregometry, prothrombin time, activated partial thromboplastin time, platelet count and fibrinogen in patients on anti-platelet drug therapy.
Biochem Med (Zagreb). 2017; 27(1):217-224 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Fröhlich, E Hemocompatibility of inhaled environmental nanoparticles: Potential use of in vitro testing.
J Hazard Mater. 2017; 336(28):158-167
Web of Science PubMed FullText FullText_MUG

 

Paar, M; Rossmann, C; Nusshold, C; Wagner, T; Schlagenhauf, A; Leschnik, B; Oettl, K; Koestenberger, M; Cvirn, G; Hallström, S Anticoagulant action of low, physiologic, and high albumin levels in whole blood.
PLoS One. 2017; 12(8):e0182997-e0182997 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Pabinger, I; Fries, D; Schöchl, H; Streif, W; Toller, W Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis.
Wien Klin Wochenschr. 2017; 129(9-10):303-316 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2016

Cadamuro, J; Skocic, M; Meisl, B; Raggam, RB; Felder, TK; Prüller, F; Reinstadler, K; Wiedemann, H; Mrazek, C A diagnostic algorithm for the detection of inhibitors against coagulation Factor V.
Clin Chem Lab Med. 2016; 54(7):e203-e206 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Fröhlich, E Action of Nanoparticles on Platelet Activation and Plasmatic Coagulation.
Curr Med Chem. 2016; 23(5):408-430 [OPEN ACCESS]
Web of Science PubMed PUBMED Central

 

2014

Gary, T Cancer related venous thromboembolism - prophylaxis and therapy.
Vasa. 2014; 43(4):245-251
Web of Science PubMed FullText FullText_MUG

 

2013

Lu, J; Roth, RA; Malle, E; Ganey, PE Roles of the hemostatic system and neutrophils in liver injury from co-exposure to amiodarone and lipopolysaccharide.
Toxicol Sci. 2013; 136(1):51-62 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2012

Doliska, A; Strnad, S; Stana, J; Martinelli, E; Ribitsch, V; Stana-Kleinschek, K In vitro haemocompatibility evaluation of PET surfaces using the quartz crystal microbalance technique.
J Biomater Sci Polym Ed. 2012; 23(5):697-714
Web of Science PubMed FullText FullText_MUG

 

Philipose, S; Konya, V; Lazarevic, M; Pasterk, LM; Marsche, G; Frank, S; Peskar, BA; Heinemann, A; Schuligoi, R Laropiprant Attenuates EP3 and TP Prostanoid Receptor-Mediated Thrombus Formation.
PLoS One. 2012; 7(8):e40222-e40222 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2011

Cvirn, G; Hoerl, G; Tafeit, E; Heinl, N; Wodrig, K; Wagner, T; Koestenberger, M; Juergens, G Effects of Nadroparin, Enoxaparin, and Unfractionated Heparin on Endogenous Formation of Factor Xa and IIa and on Thrombelastometry Profiles in Cord versus Adult Blood.
Neonatology. 2011; 100(1): 23-31.
Web of Science PubMed FullText FullText_MUG

 

Equinox Investigators Efficacy and safety of once weekly subcutaneous idrabiotaparinux in the treatment of patients with symptomatic deep venous thrombosis.
J Thromb Haemost. 2011; 9(1):92-99 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Novak, M; Schlagenhauf, A; Bernhard, H; Schweintzger, S; Leschnik, B; Muntean, W Effect of rivaroxaban, in contrast to heparin, is similar in neonatal and adult plasma.
Blood Coagul Fibrinolysis. 2011; 22(7): 588-592.
Web of Science PubMed FullText FullText_MUG

 

Wolf, D; Hohmann, JD; Wiedemann, A; Bledzka, K; Blankenbach, H; Marchini, T; Gutte, K; Zeschky, K; Bassler, N; Hoppe, N; Rodriguez, AO; Herr, N; Hilgendorf, I; Stachon, P; Willecke, F; Duerschmied, D; von zur Muhlen, C; Soloviev, DA; Zhang, L; Bode, C; Plow, EF; Libby, P; Peter, K; Zirlik, A Binding of CD40L to Mac-1's I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis--but does not affect immunity and thrombosis in mice.
CIRC RES. 2011; 109(11): 1269-1279. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2010

Gary, T; Pruller, F; Froehlich, H; Werner, S; Hafner, F; Brodmann, M Proximal lower limb vein thrombosis following vipera berus hand bite.
Vasa. 2010; 39(2):199-201 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Philipose, S; Konya, V; Sreckovic, I; Marsche, G; Lippe, IT; Peskar, BA; Heinemann, A; Schuligoi, R The Prostaglandin E2 Receptor EP4 Is Expressed by Human Platelets and Potently Inhibits Platelet Aggregation and Thrombus Formation.
Arterioscler Thromb Vasc Biol. 2010; 30(12): 2416-2423. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2009

Bernhard, H; Rosenkranz, A; Novak, M; Leschnik, B; Petritsch, M; Rehak, T; Kofeler, H; Ulrich, D; Muntean, W No differences in support of thrombin generation by neonatal or adult platelets
Hamostaseologie. 2009; 29 Suppl 1(7):S94-S97
Web of Science PubMed

 

Gurbel, PA; Bliden, KP; Saucedo, JF; Suarez, TA; DiChiara, J; Antonino, MJ; Mahla, E; Singla, A; Herzog, WR; Bassi, AK; Hennebry, TA; Gesheff, TB; Tantry, US Bivalirudin and clopidogrel with and without eptifibatide for elective stenting: effects on platelet function, thrombelastographic indexes, and their relation to periprocedural infarction results of the CLEAR PLATELETS-2 (Clopidogrel with Eptifibatide to Arrest the Reactivity of Platelets) study.
J Am Coll Cardiol. 2009; 53(8): 648-657. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2007

Cimenti, C; Koestenberger, M; Leschnik, B; Haidl, H; Muntean, W The respective and combined anticoagulant effects of recombinant human activated protein C, melagatran and heparins using CAT.
Thromb Res. 2007; 119(3): 361-367.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Cvirn, G; Gruber, HJ; Koestenberger, M; Kutschera, J; Wagner, T; Ferstl, U; Sedlmayr, P; Juergens, G; Gallistl, S High availability of intravascular tissue factor in neonates.
J PEDIAT HEMATOL ONCOL. 2007; 29(5): 279-283.
Web of Science PubMed FullText FullText_MUG

 

Siebenhofer, A; Rakovac, I; Kleespies, C; Piso, B; Didjurgeit, U Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial.
Thromb Haemost. 2007; 97(3):408-416
Web of Science PubMed FullText FullText_MUG

 

2005

Baier, K; Cvirn, G; Fritsch, P; Köstenberger, M; Gallistl, S; Leschnik, B; Muntean, W Higher concentrations of heparin and hirudin are required to inhibit thrombin generation in tissue factor-activated cord plasma than in adult plasma.
PEDIAT RES. 2005; 57(5 Pt 1): 685-689. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Cvirn, G; Koestenberger, M; Leschnik, B; Male, C; Kutschera, J; Ferstl, U; Muntean, W; Juergens, G; Gallistl, S Protein S modulates the anticoagulant action of recombinant human activated protein C: a comparison between neonates and adults.
BRIT J PHARMACOL. 2005; 146(8): 1082-1086. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

Koestenberger, M; Cvirn, G; Gallistl, S; Kutschera, J; Muntean, W Recombinant human activated protein C, heparin and melagatran in umbilical cord versus adult plasma.
Acta Paediatr. 2005; 94(7):884-889
Web of Science PubMed FullText FullText_MUG

 

Koestenberger, M; Gallistl, S; Cvirn, G; Baier, K; Leschnik, B; Muntean, W Anticoagulant action of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, in umbilical cord and adult plasma: an in vitro examination.
THROMB RES. 2005; 115(1-2): 135-142.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Koestenberger, M; Gallistl, S; Muntean, W; Ferstl, U; Kutschera, J; Cvirn, G An evaluation of the procoagulant action of recombinant activated factor VII in cord whole blood versus adult whole blood using thromboelastography.
BLOOD COAGULAT FIBRINOL. 2005; 16(8): 613-617.
Web of Science PubMed Google Scholar

 

2004

Cvirn, G; Gallistl, S; Koestenberger, M; Baier, K; Fritsch, P; Greilberger, J; Jürgens, G; Muntean, W The anticoagulant action of recombinant human activated protein C (rhAPC, Drotrecogin alpha activated): comparison between cord and adult plasma.
THROMB HAEMOST. 2004; 91(5): 912-918.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Koestenberger, M; Cvirn, G; Gallistl, S; Baier, K; Leschnik, B; Muntean, W Drotrecogin alfa (activated, Xigris) in combination with heparin or melagatran: an in vitro investigation.
J THROMB THROMBOLYSIS. 2004; 18(1): 5-10.
Web of Science PubMed FullText FullText_MUG

 

Koestenberger, M; Cvirn, G; Gallistl, S; Muntean, W Drotrecogin alfa activated (recombinant human activated protein C) in combination with heparin or melagatran: effects on prothrombin time and activated partial thromboplastin time.
BLOOD COAGULAT FIBRINOL. 2004; 15(8): 693-697.
Web of Science PubMed

 

Lang, T; Toller, W; Gütl, M; Mahla, E; Metzler, H; Rehak, P; März, W; Halwachs-Baumann, G Different effects of abciximab and cytochalasin D on clot strength in thrombelastography.
J THROMB HAEMOST. 2004; 2(1): 147-153. [OPEN ACCESS]
Web of Science PubMed FullText Google Scholar

 

2003

Hummers-Pradier, E; Hess, S; Adham, IM; Papke, T; Pieske, B; Kochen, MM Determination of bleeding risk using genetic markers in patients taking phenprocoumon.
Eur J Clin Pharmacol. 2003; 59(3):213-219
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2002

Jilma, B; Marsik, C; Mayr, F; Graninger, MT; Taylor, FB; Ribel, MC; Erhardtsen, E; Handler, S; Eichler, HG Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans.
Clin Pharmacol Ther. 2002; 72(4):403-410
Web of Science PubMed FullText FullText_MUG

 

1999

Gallistl, S; Cvirn, G; Muntean, W Recombinant factor VIIa does not induce hypercoagulability in vitro.
Thromb Haemost. 1999; 81(2): 245-249.
Web of Science PubMed Google Scholar

 

Wetzka, B; Winkler, K; Kinner, M; Friedrich, I; März, W; Zahradnik, HP Altered lipid metabolism in preeclampsia and HELLP syndrome: links to enhanced platelet reactivity and fetal growth.
Semin Thromb Hemost. 1999; 25(5):455-462
Web of Science PubMed Google Scholar

 

1997

Urlesberger, B; Zobel, G; Rödl, S; Dacar, D; Friehs, I; Leschnik, B; Muntean, W Activation of the clotting system: heparin-coated versus non coated systems for extracorporeal circulation.
INT J ARTIF ORGANS 1997 20: 708-712.
Web of Science PubMed Google Scholar

 

1994

Gallistl, S; Muntean, W Thrombin-Hirudin complex formation, thrombin-antithrombin III complex formation, and thrombin generation after intrinsic activation of plasma.
Thromb Haemost. 1994; 72(3):387-392
Web of Science PubMed Google Scholar

 

Moliterno, DJ; Lange, RA; Gerard, RD; Willard, JE; Lackner, C; Hillis, LD Influence of intranasal cocaine on plasma constituents associated with endogenous thrombosis and thrombolysis.
Am J Med. 1994; 96(6):492-496
Web of Science PubMed

 

1993

Lippe, IT; Sametz, W; Sabin, K; Holzer, P Inhibitory role of capsaicin-sensitive afferent neurons and nitric oxide in hemostasis.
Am J Physiol. 1993; 265(6 Pt 2):H1864-H1868
Web of Science PubMed Google Scholar

 

1992

Kröll, W; Gerner, P; Colombo, T; Ramschak, H; Hinghofer-Szalkay, H; List, WF The effect of 6% HES 200/0.6-0.66 on plasma volume and blood coagulation
Infusionsther Transfusionsmed. 1992; 19(4):171-180
Web of Science PubMed Google Scholar

 

1980

Schenk, H; Klein, G; Haralambus, I; Goebel, R Coumarin therapy during antirheumatism therapy with sulindac
Z Rheumatol. 1980; 39(3-4):102-108
Web of Science PubMed

 

© Meduni Graz Impressum